Cost Effectiveness of Combination Therapy with Pioglitazone for Type 2 Diabetes Mellitus from a German Statutory Healthcare Perspective
Year of publication: |
2004
|
---|---|
Authors: | Neeser, Kurt ; Lubben, Georg ; Siebert, Uwe ; Schramm, Wendelin |
Published in: |
PharmacoEconomics. - Springer Healthcare | Adis, ISSN 1170-7690. - Vol. 22.2004, 5, p. 321-341
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Acarbose | Cost-effectiveness | Metformin | Pioglitazone | Sulfonylureas | Thiazolidinediones | Type-2-diabetes-mellitus |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Simons, W. Robert., (2010)
-
Tilden, Dominic P., (2007)
-
Home, Philip, (2007)
- More ...
-
Economic Evaluation of Newborn Hearing Screening: Modelling Costs and Outcomes
Hessel, Franz, (2003)
-
On the role of data, statistics and decisions in a pandemic
Jahn, Beate, (2022)
-
Authors’ response: on the role of data, statistics and decisions in a pandemic
Jahn, Beate, (2022)
- More ...